Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy with or without Immunotherapy for Peritoneal Mesothelioma (Alliance A092001)
- Citation:
- J Clin Oncol vol 41 (suppl 16) TPS8603
- Meeting Instance:
- ASCO 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882;
- Corr. Author:
- Authors:
- Aaron Mansfield Austin Goodrich Nathan Foster Vinicius Ernani Liza Villaruz Patrick Forde Kanwal Raghav Paul Romesser Krista Garbacz Diane Feldman Liang Cao Mary Salvatore Anja Roden Steven Powell Ardaman Shergill Pamela Munster Gary Schwartz Travis Grotz
- Networks:
- CA136, COLUMBIA, LAPS-IL057, LAPS-MD017, LAPS-MN026, LAPS-NY016, LAPS-PA015, LAPS-TN008, LAPS-TX035, SANFORD
- Study
- Alliance-A092001
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: